Wound healing and regeneration
When you take semaglutide, it sends signals to your brainspecifically the hypothalamusto tell your body that you are full
Mounjaro represents the first dual GIP and GLP-1 receptor agonist approved for type 2 diabetes, offering a novel mechanism of action that distinguishes it from established incretin-based therapies
They can help monitor you closely after your first few injections and discuss whether pre-treatment with antihistamines or other precautions might be appropriate
If you are taking warfarin (Coumadin), you will likely need more frequent INR blood tests when you first start a GLP-1 medication
Glucagon-like peptide-1 (GLP-1) analogs alter the activity of hypothalamic neurons in the arcuate nucleus, which are directly associated with eating behavior, thereby increasing satiety and reducing energy intake, leading to weight loss [11, 12]